Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today
that it will host a panel discussion in San Francisco, on Monday,
November 7, 2011 to review and discuss the Promacta Phase ... read more
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today
that it will host a panel discussion in San Francisco, on Monday,
November 7, 2011 to review and discuss the Promacta Phase ... read more
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today
that it has entered into a Captisol license agreement with SAGE
Therapeutics, Inc. for the development and commercialization of
... read more